Kombucha tea improves glucose tolerance and reduces hepatic steatosis in obese mice.
Gabriela V Moreira, Layanne C C Araujo, Gilson M Murata...
https://pubmed.ncbi.nlm.nih.gov/36095960/Actively Recruiting
Led by Associação Centro de Apoio Tecnológico Agro Alimentar · Updated on 2025-01-06
33
Participants Needed
2
Research Sites
N/A
Total Duration
Researchers are exploring the effects of kombucha, a fermented tea beverage, on individuals who are overweight or have class 1 obesity. This study aims to understand how kombucha, including its live microbiota, influences metabolic factors like glucose, insulin, and lipid levels, as well as gut microbiota diversity and liver function. The trial is a randomized controlled pilot study assessing these impacts through clinical and biological measures. Participants are randomly assigned to one of three groups one group drinks 33 cl of live kombucha daily, another drinks 33 cl of pasteurized kombucha daily, and a third group drinks 33 cl of sparkling water as a control. Each intervention lasts for 4 weeks, and the study includes dietary supplementation with the assigned beverage. The trial involves a triple-blind design to reduce bias. During the study, participants undergo assessments of their gut microbiota through fecal samples, fasting glucose and insulin levels, insulin resistance, lipid profiles, liver enzymes, and biomarkers of oxidative stress and inflammation. Questionnaires about gastrointestinal symptoms and stool consistency are also completed. The trial aims to measure changes over the 4-week period to evaluate kombuchas potential effects on metabolism, microbiota, and liver health.
CONDITIONS
Kombucha in Overweight and Obese: Live Vs. Pasteurized Effects on Microbiota, Metabolism, and Liver Function
I
Inês Brandão, PhD
F
Filomena Pereira, Nutritionist
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Associação Centro de Apoio Tecnológico Agro Alimentar
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 weeks
Participants consume a daily amount of 33 cl of live kombucha, pasteurized kombucha, or sparkling water for 4 weeks to assess effects on gut microbiota, metabolism, and liver function.
Weekly visits for up to 4 weeks
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Gabriela V Moreira, Layanne C C Araujo, Gilson M Murata...
https://pubmed.ncbi.nlm.nih.gov/36095960/Associação Centro de Apoio Tecnológico Agro Alimentar
Lead Sponsor